CD5 CAR T-Cells for Treatment of Patients with Relapsed/Refractory CD5 Expressing T-Cell Lymphoma Demonstrates Safety and Anti-Tumor Activity

被引：0

作者：

Hill, LaQuisa ^{[1
]}

Rouce, Rayne Helen ^{[1
]}

Smith, Tyler S. ^{[1
]}

Yang, Lina ^{[1
]}

Srinivasan, Madhuwanti ^{[1
]}

Zhang, Huimin ^{[1
]}

Perconti, Silvana ^{[1
]}

Mehta, Birju ^{[1
]}

Dakhova, Olga ^{[1
]}

Randall, Josalind ^{[1
]}

Grilley, Bambi ^{[1
]}

Heslop, Helen E. ^{[1
]}

Brenner, Malcolm K. ^{[1
]}

Mamonkin, Maksim ^{[1
]}

机构：

[1] Houston Methodist Hosp, Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

354

引用

页码：S237 / S238

页数：2

共 50 条

[31] Outcome of Patients with T-Cell Acute Lymphoblastic Leukemia/Lymphoma with Early T-Cell Precursor-like Immunophenotype with Strong CD5 Expression
Morita, Kiyomi
Kantarjian, Hagop M.
Fang, Hong
Ravandi, Farhad
Jain, Nitin
Konopleva, Marina
Siba, El Hussein
Wang, Feng
Short, Nicholas J.
Takahashi, Koichi
Khouri, Rita
Sasaki, Koji
DiNardo, Courtney D.
Kadia, Tapan M.
Garcia-Manero, Guillermo
Daver, Naval
Bravo, Guillermo Montalban
Konoplev, Sergej
Khoury, Joseph D.
Jabbour, Elias
BLOOD, 2020, 136
[32] Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies
Sui, Songnan
Li, Zhiyan
Tan, Jiaxiong
Wang, Liang
Luo, Gengxin
Zeng, Chengwu
Luo, Oscar Junhong
Chen, Cunte
Li, Yangqiu
JOURNAL OF ONCOLOGY, 2022, 2022
[33] CD5 IS PHOSPHORYLATED ON TYROSINE AFTER STIMULATION OF THE T-CELL ANTIGEN RECEPTOR COMPLEX
DAVIES, AA
LEY, SC
CRUMPTON, MJ
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6368 - 6372
[34] Celiac Disease Is Not Related to the Loss of T-cell CD5 in the Small Bowel Mucosa
Khan, Iram
Khozam, Noor
Surve, Dipti
Ozdemirli, Metin
Charabaty, Aline
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S130 - S130
[35] T-cell modulatory properties of CD5 and its role in antitumor immune responses
Tabbekh, Mouna
Mokrani-Hammani, M'Barka
Bismuth, Georges
Mami-Chouaib, Fathia
ONCOIMMUNOLOGY, 2013, 2 (01):
[36] Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma
Kedmi, Meirav
Shouval, Roni
Fried, Shalev
Bomze, David
Fein, Joshua
Cohen, Zachary
Danilesko, Ivetta
Shem-Tov, Noga
Yerushalmi, Ronit
Jacoby, Elad
Besser, Michal
Shimoni, Avichai
Nagler, Arnon
Avigdor, Abraham
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 251 - 257
[37] CD5 inhibits the activity of dendritic cells to activate T cells and induce immune responses
Xu, Hui
Li, Hui
He, Donggou
Xu, Shin
Raman, Chander
JOURNAL OF IMMUNOLOGY, 2015, 194
[38] Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma
Attygalle, AD
Al-Jehani, R
Diss, TC
Munson, P
Liu, H
Du, MQ
Isaacson, PG
Dogan, A
MODERN PATHOLOGY, 2002, 15 (01) : 229A - 230A
[39] Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma
Attygalle, AD
Al-Jehani, R
Diss, TC
Munson, P
Liu, H
Du, MQ
Isaacson, PG
Dogan, A
LABORATORY INVESTIGATION, 2002, 82 (01) : 229A - 230A
[40] T-CELL DEPLETION WITH ANTI-CD5 IMMUNOTOXIN IN HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION - THE CORRELATION BETWEEN RESIDUAL CD5 NEGATIVE T-CELLS AND SUBSEQUENT GRAFT-VERSUS-HOST DISEASE
FILIPOVICH, AH
VALLERA, D
MCGLAVE, P
POLICH, D
GAJLPECZALSKA, K
HAAKE, R
LASKY, L
BLAZAR, B
RAMSAY, NKC
KERSEY, J
WEISDORF, D
TRANSPLANTATION, 1990, 50 (03) : 410 - 415

← 1 2 3 4 5 →